Pamela A. Maher - La Jolla CA, US David R. Schubert - La Jolla CA, US
Assignee:
Salk Institute for Biological Studies - La Jolla CA
International Classification:
A61K 31/353
US Classification:
514456
Abstract:
Disclosed herein, inter alia, are methods and compositions for treating a complication of diabetes or a vascular disease using a 5-desoxy-flavone and/or 5-desoxy-flavonol.
Described herein are flavonoids (e.g., 5-desoxy flavones and/or 5-desoxy flavonols, including without limitation fisetin and its derivatives) that activate ERK and induce CREB phosphorylation in neuronal cultures, facilitate long-term potentiation in hippocampal slices and enhance object recognition in vivo. Methods of using these flavonoids, for instance, for enhancing memory are described.
The present invention provides neuroprotective polyphenol compounds, which can be synthetic analogs of fisetin, baicalein or chlorogenic acid, that maintain neuroprotective, anti-inflammatory, glutathione promoting, and/or antioxidant properties. The neuroprotective polyphenol compounds are useful for promoting, enhancing and/or increasing neuron protection, growth and/or regeneration. The polyphenol compounds further find use for increasing and or maintaining intracellular glutathione (GSH) levels. The polyphenol compounds are also useful for treating, preventing, mitigating and/or delaying neurodegenerative conditions, including diabetes, Parkinson's disease, Huntington's disease, Alzheimer's disease, non-Alzheimer's dementias, multiple sclerosis, traumatic brain injury, spinal cord injury or ALS.
The present invention provides neuroprotective polyphenol compounds, which can be synthetic analogs of fisetin, baicalein or chlorogenic acid, that maintain neuroprotective, anti-inflammatory, glutathione promoting, and/or antioxidant properties. The neuroprotective polyphenol compounds are useful for promoting, enhancing and/or increasing neuron protection, growth and/or regeneration. The polyphenol compounds further find use for increasing and or maintaining intracellular glutathione (GSH) levels. The polyphenol compounds are also useful for treating, preventing, mitigating and/or delaying neurodegenerative conditions, including diabetes, Parkinson's disease, Huntington's disease, Alzheimer's disease, non-Alzheimer's dementias, multiple sclerosis, traumatic brain injury, spinal cord injury or ALS.
The present invention provides methods of use of polyphenol compounds for treating, preventing, mitigating and delaying ischemia or a condition where ischemia occurs. In one embodiment, the method comprises providing a polyphenol analog; and administering the polyphenol analog to a subject to treat ischemia or a condition where ischemia occurs. Various embodiments of the present invention are useful for the treatment of patients having, or at risk for, any of (1) ischemic stroke, (2) hemorrhagic stroke, (3) cardiovascular disease, (4) ischemia related spinal cord injury, (5) ischemia in diabetic patients, or (6) embolic stroke. For example, use of the polyphenol compounds can maintain glutathione levels in the patient.
Gregory M. Cole - Santa Monica CA, US Sally A. Frautschy - Santa Monica CA, US David R. Schubert - La Jolla CA, US Pamela A. Maher - La Jolla CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA DEPARTMENT OF VETERANS AFFAIRS - Washington DC SALK INSTITUTE FOR BIOLOGICAL STUDIES - La Jolla CA
International Classification:
A61K 31/353 A61K 31/202
US Classification:
514456
Abstract:
Nutraceutical formulations that improve cognitive function in adults diagnosed with neurodegenerative disease are provided, which comprise a combination of fisetin and DHA.
Course Writer at Regis University College for Professional Studies, Affiliate Faculty at Regis University College for Professional Studies, Instructor at University of Nevada Las Vegas, NASA Nevada Educator Resource Center Coordinator at College of Southern Nevada
Location:
Las Vegas, Nevada
Industry:
Higher Education
Work:
Regis University College for Professional Studies since May 2013
Course Writer
Regis University College for Professional Studies - Las Vegas, Nevada Area since 2012
Affiliate Faculty
University of Nevada Las Vegas - Las Vegas, Nevada Area since 2012
Instructor
College of Southern Nevada since Jan 2007
NASA Nevada Educator Resource Center Coordinator
Pacific University Sep 2000 - Aug 2005
Program Associate / Graduate School
Education:
University of Nevada-Las Vegas 2011 - 2017
Ph.D., Science Education
Lewis and Clark College 1980 - 1984
M.A.T, Education
Oregon State University 1973 - 1977
B.A., Art Education
Not only does CBN have neuroprotective properties, but its derivatives have the potential to become novel therapeutics for various neurological disorders, said Research Professor Pamela Maher, the senior author of the study. We were able to pinpoint the active groups in CBN that are doing that ne